RECURRENCE OF CHCV AFTER THE USE OF DIRECT ANTIVIRAL DRUGS: CLINICS, DIAGNOSIS, TREATMENT AND OUTCOMES

ORIGINAL SOURCE
Originally published in INTERNATIONAL CONFERENCE ON MEDICINE, SCIENCE, AND EDUCATION; Vol. 1 No. 4 (2024): INTERNATIONAL CONFERENCE ON MEDICINE, SCIENCE, AND EDUCATION; 98-99.
View & download PDFOpen original source

Jurayev J.S. and Karshiev.M.A and Uralov, A.A (2024) RECURRENCE OF CHCV AFTER THE USE OF DIRECT ANTIVIRAL DRUGS: CLINICS, DIAGNOSIS, TREATMENT AND OUTCOMES. INTERNATIONAL CONFERENCE ON MEDICINE, SCIENCE, AND EDUCATION; Vol. 1 No. 4 (2024): INTERNATIONAL CONFERENCE ON MEDICINE, SCIENCE, AND EDUCATION; 98-99.

[thumbnail of 1651.pdf] PDF
1651.pdf - Published Version
Download (166kB)

Abstract

Viral hepatitis C is one of the leading liver diseases. According to WHO, 70 million people are infected with this disease. HCV kills 290,000 people every year. In 95% of patients, the disease becomes chronic, and the main complications are fibrosis and cirrhosis of the liver. In some cases, a relapse is observed, despite treatment with antiviral drugs.

Item Type: Article
Additional Information: Imported from International Conference on Medicine, Science, and Education
SWORD Depositor: Admin User
Depositing User: Admin User
Date Deposited: 22 Sep 2026 22:35
Last Modified: 22 Sep 2026 22:35
URI: https://universalpublishings.uz/id/eprint/4245

Actions (login required)

View Item
View Item